Risk of Second Tumors and T-Cell Lymphoma after CAR T-Cell Therapy. Godfrey J, Querfeld C, Song J. N Engl J Med 2024;391:869-870.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Godfrey J, Querfeld C, Song J. Risk of Second Tumors and T-Cell Lymphoma after CAR T-Cell Therapy. N Engl J Med 2024;391:869-870.
PMID: 39231354